Skip to content

The Ophthalmology Innovation Summit unites Industry, Entrepreneurial and Clinical Leaders.
Below are the companies who are signed up to date to attend.


Ted Danse, Chief Business Officer

Aerie Pharmaceuticals
Vince Anido, Chairman & CEO
Puiwah Braswell, Clinical Trials Manager
Eric Carlson, VP, Head, R&D
Rick Halprin, Director, Professional Affairs
Theresa Heah, VP, Clinical Research, Medical and Professional Affairs
Mark Herring, VP, Clinical Research
Cheng-Wen Lin, Director, Drug Delivery & Pharmacology
Jae Lopez, Clinical Trial Manager
Mike McCleerey, VP, Portfolio Development
Hayley McKee, Director, Clinical Research
Chyong Nien, Manager, Clinical Science
Nancy Ramirez-Davis, Director, Clinical Project Management
Richard Rubino, CFO
Huan Sheng, Director, Clinical Research & Drug Safety
Stuart Williams, Director, Research

Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Franck Leveiller, Global Head, R&D

Alimera Sciences
Rick Eiswirth, President & CFO
Dan Myers, CEO

Allegro Ophthalmics
Scott Cooper, CFO
Michele Gray, Marketing & Communications
Hampar Karageozian, CEO
Vicken Karageozian, MD, President & Chief Medical Officer
Melvin Sarayba, MD, VP, Clinical Affairs

Tirso Alonso, Executive Medical Director
James Cunningham, Executive Director
David Nicholson, PhD, Chief R&D Officer

Allied Minds
Omar Amirana, MD, Senior Vice President

Austin Retina Associates
Robert Wong


Bausch + Lomb
David Fisher, VP, Marketing
Charles Hess, VP & General Manager, US Surgical
Calvin Roberts, MD, SVP & Chief Medical Officer

Bern University Hospital
Andreas Ebneter, Vitreo-Retinal Surgeon

Bionic Vision Technologies
Tamara Brawn, Head, Product Development
Julie Anne Quinn, CEO

BroadSpot Imaging
Bart Bandy, CEO & President

Brown Retina Institute
Jeremiah Brown, MD, President

Bryn Mawr Communications
Janet Burk, Publisher
Ranna Jaraha, Director of New Media
David Levine, EVP Digital & Custom Media
Karen Roman, Editor-in-Chief, Retina Today

Shervin Korangy, CFO


California Retina Consultants
Dante Pieramici, MD, Partner

Carl Zeiss Meditec
Kevin Langton, Director, Global ODX Professional Education
Jim Mazzo, Global President, Ophthalmic Devices
Scott Meyer, Director, Strategic Business Development
Chad Miles, National Director, US Ophthalmic Diagnostics
Angelo Rago, Global Head, Ophthalmic Diagnostics

Carle Physician Group
Michael Tsipursky, MD, Retina Specialist

Cell Care Therapeutics
Nicolas Sohl, CEO

Charles Retina Institute
Steve Charles, MD, Founder & Chairman

Kyle Bechter, Director of Sponsorship Sales

Chengdu Kanghong Pharmaceutical Group
Li Liu, PhD
Associate Director, Corporate Development

Joshua Parks, Founder

Clarion Healthcare
Carol Kearney, Managing Director

Emmett Cunningham, Jr., MD, PhD, MPH, Managing Director

Clearside Biomedical
Charlie Deignan, CFO
Carol Hoang, VP, Medical Affairs
Rick McElheny, VP, Corporate Development
Glenn Noronha, PhD, Chief Scientific Officer
Brion Raymond, Chief Commercial Officer
Daniel White, President & CEO

ClearView Healthcare Partners
Debbie Zhuang, Principal

Cole Eye Institute
Peter Kaiser, MD, Professor, Ophthalmology

Compact Imaging
Don Bogue, CEO


Dalton & Associates/OIS
Michelle Dalton, Contributing Writer, OIS

Davis Duehr Dean
Mitch Wolf, MD

Deerfield Management
Cameron Wheeler, Principal

DigiSight Technologies
Douglas Foster, CEO

Doheny & Stein Eye Institutes David Geffen School of Medicine at UCLA
Ali Khan, Assistant Professor of Ophthalmology

Dr. Shelley Boyd Medical Professional Corp
Shelley Boyd, MD, Director

Drusolv Therapeutics
John Edwards, CEO


Etani Fajardo, Executive Director, Business Development
Luca Sergio, CEO & Owner
Mike Smolinsky, Chief Content Officer

Evolve Medical Education
Alan Guralnick, President

Evolve Therapeutics
Donald Fishbein, President

ExSight Ventures
Firas M. Rahhal, MD, Partner

Jay Cormier, CEO

EyePoint Pharmaceuticals
Leonard Blum, EVP & General Manager, U.S.
Thomas Hadley, VP, Marketing & Sales
Dario Paggiarino, MD, Chief Medical Officer
Keyur Patel, Senior Director, Medical Affairs
Josh Pettit, National Sales Manager
Michelle Poole, Senior Director, Marketing


ForSight Labs
Eugene de Juan, Founder & Managing Partner
Angela Macfarlane, Managing Member

Foundation Fighting Blindness
Jason Menzo, COO


Anthony Adamis, MD, SVP, Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development
Michael Verheecke, CI Manager

GenSight Biologics
Barrett Katz, MD, Chief Medical Officer

Graybug Vision
Jeffrey Cleland, PhD, President & CEO
Daniel Salain, Chief Operating Officer
Charles Semba, Chief Medical Officer


Heidelberg Engineering
Kfir Azoulay, VP & Head, Corporate Strategy
Kester Nahen, PhD, Managing Director


Suzanne Grant, CEO & Co-Founder

iRenix Medical
David Robinson
Commercial Strategy Lead - Consultant

Stephen Smith
Founder & CEO

Iconic Therapeutics
William Greene, MD, CEO

InFocus Capital Partners 
Ron Weiss, MD, Managing Member

InFocus Clinical
Brad Doerschuk, President, CEO

Interface Biologics
Wendy Naimark, PhD, VP, R&D
Thomas Reeves, President & CEO

InterWest Partners
Gilbert H. Kliman, MD, Managing Director

Laura Elias, PhD, Head, Biopharma Partnerships

iRenix Medical
Stephen Smith, Founder & CEO

Istanbul Bilim University
Murat Oncel, MD, Professor, Ophthalmology

iuvo BioScience
Benjamin Burton, President & CEO


Penny Fleck, CDTL
Scott Lundeen, Business Development


Kang Hong Pharmaceutical
Andrew Liu, VP Corporate Development


Leica Microsystems 
Steve Milazzo, Regional Sales Manager

Saiid Davari, VP Investigator Relations
Siobhan Garbutt, Associate Director, Clinical Studies
Chad Ice, CEO
Michael Schiewe, Director, Strategic Programs

Lifecore Biomedical
Kipling Thacker, CSO & VP

Longitude Capital
Greg Grunberg, MD, Managing Director


Devinder Chauhan, Founder

Midwest Eye Institute
Raj Maturi

Moran Eye Center, University of Utah
Paul Bernstein, MD, PhD, Professor, Ophthalmology & Visual Sciences

Multi Radiance Medical
Thomas Kelly, President


Needham & Co.
Serge Belanger, Analyst

Kenneth Mandell, MD, PhD, Chief Medical Officer
Rich Small, CEO

New England Eye Center
Caroline Baumal

Northern California Retina Vitreous Associates
Mark Wieland, MD

Northwest Eye Surgeons
Paul Griggs, MD

Notal Vision
Scott Jones, Chief Commercial Officer
Susan Orr, OD, Chief Medical Officer & VP, Medical Affairs
Quinton Oswald, CEO

Akshay Bhargava, Manager
Fred Ellis, Head, Professional Affairs
Frederic Guerard, Head, Worldwide Business Franchise
Karen Netherton, Global Patient Access Head, Ophthalmology
Gregg Stanhope, Director, Professional Affairs

NuSight Medical
Robert Foster, CEO


Sean McDonald, President & CEO

Alan Wells, Chief Science Advisor

Ocunexus Therapeutics
Brian Levy, CEO

ONL Therapeutics
John Freshley, President & CEO

Ophthalmology Times
Julianne Mobilian, Associate editor
Sheryl Stevenson, Group Editorial Director

Steve Brocchini, Co-founder & Chief Scientist
Barry Butler, Co-Founder & Business Development
Chris Redhead, CEO


Pacific Eye Associates / CPMC
Anne Fung, MD, Medical Retina Specialist

PANOPTiK Compliance Solutions
Jeffrey Lenk, President

Patterson Thuente
Paul Onderick, Eye Doctor & Patent Attorney

Jennifer Ford, Senior Managing Editor

Pepose Vision Institute
Nancy Holekamp, Director, Retinal Services

Photoswitch Therapeutics
John G. Flannery, PhD, Professor

Piper Jaffray
Jamie Adolph, Associate
Jeff Ammerman, Managing Director
Andrew Gitkin, Head, West Coast Biotechnology Investment Banking
Udit Patel, Principal, Healthcare Investment Banking

Precise Bio
Lior Shav, VP, Business Development

Promedica International
Khan Lau, Director, Clinical Operations

ProQr Therapeutics
Peter Adamson, Head, Ophthalmology Research
Daniel de Boer, CEO


Kim Gun-Ho, CEO

Abby Cahn, Associate Director New Products Marketing
Karen Chu, Executive Director, Clinical Strategy and Execution, Ophthalmology
Neil Levine, Executive Director Marketing
Lucille LoTempio, PharmD, BCPS, Associate Director, Medical Affairs, Ophthalmology
John Magliocchetti, Senior Director Ophthalmology New Products Marketing
Bryce Miller, Director, Strategic Accounts
David Waintraub, Associate Manager, Ophthalmology Marketing

Retina Group of Florida
Kevin Kelly

Retina Center of Maine
Mark Balles, MD, Retina Specialist

Retina Consultants of Houston
Charles Wykoff, MD

Retina Foundation of the Southwest
Karl Csaky, MD, Managing Director & Chief Medical Officer (Also representing: T. Boone Pickens Director - Clinical Center of Innovation for AMD)

Retinal Protection Sciences
Jeffrey Luttrull, MD (Also representing: Ojai Retinal Technologies)

Retina Specialist Magazine
Rich Kirkner, Editor

Retina-Vitreous Associates Medical Group
David Boyer, MD

Daniel Schwartz, MD, Professor

Dominic Sauvageau, CTO

RFE Pharma
Alan Franklin, MD, PhD, Chief Medical Officer


Frank Chen, Innovation Project Manager
Elo Kent, Head, Global Innovation Office
Ken Shimokawa, President & Chief Investment Officer

SciFluor Life Sciences - Allied Minds
Ben Askew, VP, Research
D. Scott Edwards, PhD, VP & GM

John Clement, Executive Vice President

Second Sight Medical Products
Jonathan Will McGuire, President & CEO

Susan Benton, Head of Global Franchise Strategy and New Products, Ophthalmology
Robert Dempsey, Group VP & Head, Global Ophthalmics Franchise
Eric Olson, Head, Ophthalmics BD
Amir Shojaei, VP, Therapeutic Area Head - Ophthalmology Global Clinical Development

Southern California Permanente Group (Kaiser Permanente)
Vi Hau, MD, PhD, Vice-Chair Research

Spark Therapeutics
Fatima Ahmad, Medical Communications Lead
Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology
Gabrielle Dauster, Senior Product Manager
Paulo Falabella, Medical Affairs Ophthalmic Lead
Parag Meswani, PharmD, MBA, Head of Marketing and Diagnostics
Tami Smith, Head of Medical Affairs

Springfield Clinic
Ramanath Bhandari, MD

Syneos Health
Nicholas Spittal, VP, Clinical Development


Take One Prod.
Russell Welch, Editor
Matt Worley, Producer

Tauber Eye Center
Joseph Tauber, CEO

Texas Retina Associates
Ashkan Abbey, MD, Medical and Surgical Retinal Specialist

The Macula Center
Dana Deupree

The Wyanoke Group
Peter Slack, President

Topcon Healthcare Solutions
Tobias Kurzke, Product Manager, Clinical Applications
John Trefethen, Global Head, Marketing

Trial Runners
Brandon Beaudoin, Director, Clinical Development
Patrick Healy, MPH, Co-Founder, Executive Chairman
Kelsey McDonald, Strategic Accounts Director
Emily Murphy, Marketing Manager

TrueVision Systems
Mark Maire, EVP Sales & Business Development


USC Roski Eye Institute, Keck Medicine of USC
Amir H. Kashani, Assistant Professor, Clinical Ophthalmology

Houman Hemmati, Assistant Professor

University of Southern California & Los Angeles County - USC Medical Center
Grace Chang, MD, PhD, Adjunct Clinical Assistant Professor, Ophthalmology

University of Washington
Tom Reh, Professor, Department of Biological Structure


Shawn Sharon, Director

Versant Ventures
William J. Link, PhD, Managing Director

Vestrum Health
Nadeem Ahmad, Chief Operating Officer
Tom Brogan, CEO
Genevieve Lucas, Senior Director, Client Services

ViewPoint Therapeutics
Leah Makley, CEO

Visionary Venture Fund
Jeffry Weinhuff, Managing Partner

Blake Michaels, President & CEO


Wilmer Institute Johns Hopkins University School of Medicine
Susan Bressler, MD, Professor of Ophthalmology

Peter Gehlbach, MD, PhD, Professor of Ophthalmology


ZeaVision Holdings
Pinakin Davey (Also Professor and Director of Research at Western University, College of Optometry)
Emily Frank, Vice President, Business Development


Jim Taylor, CEO

4D Molecular Therapeutics
David Kirn, CEO & Co-Founder

Scroll To Top